Q5107 is a valid 2023 HCPCS Code that could be used to indicate Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg for reimbursement purposes.
Q5107 belongs to Medical Care Type of Service and has been in effect since Jan 01, 2019.
Inj mvasi 10 mg
Q5107 code information
| HCPCS code: | Q5107 |
| Description: | INJECTION, BEVACIZUMAB-AWWB, BIOSIMILAR, (MVASI), 10 MG |
| Effective Date: | Jan 01, 2019 |
| Added Date: | Jan 01, 2019 |
| Termination Date: | HCPCS Q5107 was terminated on Nov 30, -0001 |
| Pricing indicator: | 51 - DRUGS |
| Multi Pricing indicator: | A - NOT APPLICABLE AS HCPCS PRICED UNDER ONE METHODOLOGY |
| Coverage code: | D - SPECIAL COVERAGE INSTRUCTIONS APPLY |
| BETOS code: | O1E - OTHER DRUGS |
| Action code: | N - NO MAINTENANCE FOR THIS CODE |
| Type of Service: |
1 - MEDICAL CARE
P - LUMP SUM PURCHASE OF DME, PROSTHETICS, ORTHOTICS
|
| Anesthesia BUQ: | 0 |
Below a selection of HCPCS codes related to Q5107